Abstract: Recovering a continuous colormap from a single 2D scalar field visualization can be quite challenging, especially in the absence of a corresponding color legend. In this paper, we propose a ...

Abstract: Methods and datasets for human pose estimation focus predominantly on side- and front-view scenarios. We overcome the limitation by leveraging synthetic data and introduce RePoGen (RarE ...

Golf legend Phil Mickelson is no longer a member of his longtime Southern California club after inappropriate behavior with a staff member was alleged, Golf Digest reported. Limited time: Save 25% on ...

We got a short trailer with no real gameplay at the latest Nintendo Direct. For the uninitiated, The Legend of Zelda: Ocarina of Time was the very first 3D Zelda. It launched for the N64 all the way ...

Legend Biotech remains a buy as Carvykti's earlier-line use drives superior efficacy, safety, and manufacturing success, signaling a structural shift in multiple myeloma therapy. Recent CARTITUDE-4 ...

Shares of Legend Biotech rose more than 40% Tuesday—on pace for the stock's biggest percentage increase on record—after the company said its experimental cancer treatment shrank tumors in all six ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

US biotech Legend Biotech (NASDAQ: LEGN) has reported early first-in-human data for LB2501, its investigational in vivo CAR-T therapy for relapsed or refractory B-cell non-Hodgkin lymphoma, triggering ...

Promising Phase 1 data for LB2501, a potential first‑in‑class CD19/CD20 dual‑targeting in vivo CAR-T therapy, as an off-the-shelf, single-infusion treatment for B‑cell malignancies An ORR of 100% (6/6 ...